×

GE.com has been updated to serve our three go-forward companies.

Please visit these standalone sites for more information

GE Aerospace | GE Vernova | GE HealthCare 

Press Release

Mind the talent gap: new biologics facility to upskill Australia's future workforce

July 25, 2019

The opening of a new $11.5m biotech production and training facility at the University of Technology Sydney (UTS) has been welcomed by government and industry leaders who say fostering and keeping local talent in the burgeoning Life Sciences sector is key to building a globally competitive industry.

At the facility launch today, UTS Vice-Chancellor Professor Attila Brungs said the Biologics Innovation Facility (BIF) is a great example of industry, government and university collaboration to drive the jobs of the future in an emerging industry.

business unit
tags
header-image
Cell Therapy

Pump Up The Volume: ‘Genome Sculpting’ Could Help Scale Biotherapeutic Medicine

March 15, 2017

The first biopharmaceutical drugs using complex organic molecules produced by genetically modified cells to deliver more efficient therapies have already started to write the next chapter of medicine. Treatments designed from lab-made versions of large proteins are now being used to treat cancers and autoimmune disorders like multiple sclerosis. Research shows they might also do well against infectious diseases.

header-image
Biologics

These Synthetic Snippets Of DNA Could Make A New Generation Of Drugs Available To All

January 24, 2017
There’s more to protein than steak, eggs and the South Beach Diet. The complex molecules encoded by our DNA are the workhorses of our cells, being responsible for growth, maintenance and repair.
The human body holds many thousands of different proteins, and even small typos in the genetic code can lead to diseases and conditions such as diabetes, hemophilia, dwarfism and many others.
header-image
Biologics

Gone Protein Fishing: Sweden Is Building A Hub For Medicine’s Future In The Home Of Its Past

July 20, 2016
The Swedish town of Uppsala has been a center of medical innovation for the past 350 years. In 1663, the University of Uppsala opened an anatomical theatre built into the cupola of the Gustavianum, the main building on the Uppsala University campus. Inside, future doctors and also the paying public watched from narrow, tiered, octagonal balconies as professors dissected executed criminals and animals.
header-image
Biologics

Think Inside The Box: Pfizer Will Use GE's Mobile Biotech Factory To Make Next-Generation Drugs In China

June 30, 2016
Americans and Europeans are most likely to die from heart disease. But in China, the leading cause of death is cancer. The disease killed nearly 3 million Chinese in 2015 alone and the country's doctors have few drugs available to fight the epidemic. As grim as the numbers look, they could soon start changing. That's because healthcare reforms recently enacted by the Chinese government support local production of a next-generation class of drugs called biopharmaceuticals and new, flexible drug production methods.
header-image

New Class of Personalized Drugs Will Fight Cancer, Immune Disorders. But Making Them is not Easy

March 03, 2015
For millennia, sick people swallowed simple chemicals to get better. From botanical remedies used by people in ancient Mesopotamia, to penicillin, most common drugs are built from molecules with a few dozen atoms that are relatively easy to make.But a new class of medicines made from strings of complex proteins is now leading the charge against disease.
Subscribe to Biopharmaceuticals